Attached files

file filename
EX-10.12 - EXHIBIT 10.12 - FEMASYS INCnt10019541x5_ex10-12.htm
EX-10.7 - EXHIBIT 10.7 - FEMASYS INCnt10019541x5_ex10-7.htm
EX-10.5 - EXHIBIT 10.5 - FEMASYS INCnt10019541x5_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - FEMASYS INCnt10019541x5_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - FEMASYS INCnt10019541x5_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - FEMASYS INCnt10019541x5_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - FEMASYS INCnt10019541x5_ex10-1.htm
EX-4.4 - EXHIBIT 4.4 - FEMASYS INCnt10019541x5_ex4-4.htm
EX-4.3 - EXHIBIT 4.3 - FEMASYS INCnt10019541x5_ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - FEMASYS INCnt10019541x5_ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - FEMASYS INCnt10019541x5_ex4-1.htm
EX-3.4 - EXHIBIT 3.4 - FEMASYS INCnt10019541x5_ex3-4.htm
EX-3.3 - EXHIBIT 3.3 - FEMASYS INCnt10019541x5_ex3-3.htm
EX-3.2 - EXHIBIT 3.2 - FEMASYS INCnt10019541x5_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - FEMASYS INCnt10019541x5_ex3-1.htm
S-1 - S-1 - FEMASYS INCnt10019541x5_s1.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors 

Femasys Inc.:

 

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus. Our report dated March 17, 2021 contains an explanatory paragraph that states that the Company has suffered recurring losses from operations and has a net capital deficiency that raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of that uncertainty.

 

/s/ KPMG LLP

 

Atlanta, Georgia

May 14, 2021